Billionaire Profile
Ye Chenghai & family
Global Rank
#995

Image: Unsplash Contributor | Unsplash License | via Unsplash

Ye Chenghai & family

CEO, Pharmaceuticals
HONG KONG
Real-Time Net Worth
$4.293B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-3.52% (24h)
Age
82
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
HONG KONG

Biography

Ye Chenghai, born on August 15, 1943, is a prominent figure in the Chinese business world, best known for founding and leading Shenzhen Salubris Pharmaceuticals. From humble beginnings in Meizhou, Guangdong, Ye transitioned from a political career, where he served as the Vice Mayor of Shenzhen, to become a successful entrepreneur in the pharmaceutical industry. His strategic vision and leadership transformed Shenzhen Salubris Pharmaceuticals into a leading company in China, specializing in cardiovascular, anti-infection, and anti-cancer drugs. As of 2024, his net worth is estimated at $3.8 billion, reflecting his significant achievements and contributions to China's healthcare sector. He is known for his focus on business and family, including his son Kevin, who serves as the CEO of Shenzhen Salubris Pharmaceuticals, and his daughter Ye Yujun who is a board member of the company.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Political Career

Ye Chenghai was born in Meizhou, Guangdong, China, on August 15, 1943. He belongs to the Hakka ethnic group. He studied international politics at Renmin University of China. After graduating in 1968, he was assigned to Bao'an County, the predecessor of Shenzhen. Ye held various positions in Shenzhen, including serving as a member of the municipal party standing committee, party secretary of Luohu District, and Vice Mayor of Shenzhen.

Rise to Success

Ye Chenghai resigned from his government role in 1985 and entered the business world. He founded and held positions in multiple companies, including Hong Kong-based Meizhou International Trade. His major achievement was transforming Shenzhen Salubris Pharmaceuticals into a prominent pharmaceutical company, making significant contributions to China's healthcare sector.

Key Business Strategies

Ye's primary business venture is Shenzhen Salubris Pharmaceuticals, specializing in the research, development, and production of pharmaceutical products. Under his leadership, the company experienced remarkable growth. In September 2022, Ye resigned as chairman and continued as a director; his son, Ye Yuxiang (Kevin Sing Ye), was appointed chairman.

Philanthropy

Ye has served as a vice chairman of Renmin University of China's board. In April 2024, Renmin University of China announced the establishment of the Chenghai Institute for Global Development and Security, funded by Ye's donation.

Career Milestones

1968

Graduated from Renmin University of China

Obtained a degree in international politics.

1985

Entered the business world

Resigned from his role as Vice Mayor of Shenzhen.

1998

Founded Shenzhen Salubris Pharmaceuticals

Established and led the company, transforming it into a leading pharmaceutical enterprise.

2022

Resigned as Chairman of Shenzhen Salubris Pharmaceuticals

Remained as a director of the company while his son, Kevin Ye, became chairman.

2024

Supported the establishment of the Chenghai Institute

Funded the Chenghai Institute for Global Development and Security at Renmin University of China.

Philanthropy & Social Impact

Education and Security

Chenghai Institute for Global Development and Security

Unknown

Funded the establishment of the institute at Renmin University of China.